Know Cancer

or
forgot password

Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain


N/A
18 Years
75 Years
Not Enrolling
Both
Ulcer, Wounds and Injuries

Thank you

Trial Information

Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain


Inclusion Criteria:



- Moderate to severe resting pain (scores above 5/10).

- Stable analgesic regimen.

- No surgical interventions planned during the study period.

- Able to self-assess pain and report it.

- Hospitalized or receiving home care for Stage I; out-patients or receiving home care
for Stage II.

- Wound not infected or covered with necrotic tissue.

Exclusion Criteria:

- True sensitivity to opioids

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

pain intensity reports

Principal Investigator

Pesach Shvartzman, Professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Ben-Gurion University of the Negev, Sial Research Center for Family Medicine and Primary Care

Authority:

Israel: Ministry of Health

Study ID:

SOR394105CTIL

NCT ID:

NCT00306020

Start Date:

January 2006

Completion Date:

June 2012

Related Keywords:

  • Ulcer
  • Wounds and Injuries
  • Skin ulcers
  • Topical morphine
  • Chronic pain
  • Cancer
  • Ulcer
  • Wounds and Injuries

Name

Location